Genome‐wide association studies have demonstrated that the patatin‐like phospholipase 3 (PNPLA3) GG single‐nucleotide polymorphism (SNP; rs738409 [G] encoding I148M) increases the risk of NAFLD development and HCC.3 The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.